细菌群体感应与Ⅱ类乳酸菌细菌素的合成调控

Ⅱ类乳酸菌细菌素具有抑菌谱广,尤其对单核细胞增生李斯特菌表现出强抑制作用,被视为一类新型、安全的天然食品防腐剂,具有广泛应用前景,但合成量低是目前限制其应用的瓶颈之一。群体感应是细菌细胞间的相互交流,从而感知自身信号分子浓度进行基因表达调控的一种生理行为,已经证明乳酸菌群体感应系统能调控细菌素的合成。本文综述了细菌群体感应调控机制及其对乳酸菌细菌素生物合成调控的作用,为通过群体感应系统调控提高乳酸菌细菌素的产量提供思路。     

群体感应系统调控乳酸菌细菌素合成的研究进展

乳酸菌细菌素具有广谱的抑菌活性,但其合成量低,限制了行业应用。群体感应是细胞间的通信过程,细菌通过感知信号分子浓度变化,调控相关的生物学过程。三组分系统在调控细菌素合成的过程中发挥了核心作用。本文中,笔者综述了调控乳酸菌细菌素合成的三组分系统的组成、Ⅰ类和Ⅱ类细菌素合成调控的基因与结构的差异性以及细菌密度和共培养等因素对细菌素的合成的影响,以阐明乳酸菌素合成的群体感应调控机制,对于其在食品、生物和医疗领域的应用都有重要的意义。     

乳酸菌群体感应系统研究进展

群体感应及其自我调控是细菌间进行信息交流的重要机制。细菌通过特定的化学信号分子来监测菌群密度和周围环境的变化,进而调节菌体内相关基因表达,使菌体更加适应周围环境。乳酸菌很多生物学现象都与群体感应系统有关。本文中,笔者总结了乳酸菌群体感应系统的组成、信号转导机制及其生物学功能,这些功能包括调控菌体生物膜的形成、菌株自溶、抗菌肽的合成、酸胁迫应答。本综述将为乳品工业提高乳酸菌的发酵密度和扩大其益生菌功能提供新思路。     

乳酸菌群体感应与其肠道生物膜形成的研究进展

肠道内栖息着数量庞大且复杂的微生物菌群,是一个具有生物多样性的微环境,菌群在调节宿主肠道健康中发挥着重要作用。群体感应(quorumsensing,QS)是细菌间通过化学信号分子进行信息传递的重要方式。本文综述了QS系统组成、信号转导机制及AI-2/LuxS系统对肠道生物膜形成的调控,介绍了乳酸菌AI-2/LuxSQS系统及其在调控生物膜形成上的作用。通过肠道乳酸菌QS与生物膜形成综述分析,旨在为肠道屏障功能和健康调控提供新思路。     

细菌群体感应信号网络及其应用

群体感应（Quorum sensing,QS）是一种细菌细胞与细胞间的通讯系统,即细菌通过分泌扩散性小分子信号感知细菌群体的密度,从而引起一组特定基因在转录水平协调表达。大量研究已表明,群体感应系统控制细菌多种生理行为和过程,以及与真核宿主（寄主）的互作。参与群体感应调控的信号分子多种多样,QS系统所调控的功能也具有多样性,甚至菌株专化性。通过聚焦同一细菌中由多个QS系统组成的信号网络,综合评述了不同QS系统之间如何相互作用全局调控基因表达,以及QS系统如何通过与其它全局调控系统整合精细调节细菌的社会行为以及环境适应性及其应用前景。     

乳酸菌双组分信号转导系统研究进展

乳酸菌中存在着一种重要的调控机制--双组分信号转导系统,它可以通过调控乳酸菌的多种生理生化过程来适应外界环境的变化.就双组分信号转导系统的组成、作用机制以及乳酸菌中调控耐酸机制、细菌素的合成和黏性吸附等生理过程的双组分信号转导系统作一综述.     

一株布氏乳杆菌所产类细菌素的初步纯化与部分特性

从分离自内蒙古传统乳制品的67株乳酸菌中筛选得到一株产生类细菌素的布氏乳杆菌KLDS1.0364, 对其所产类细菌素进行初步分离纯化, 同时研究其所产类细菌素的生物学特性。KLDS1.0364无细胞发酵上清液经阳离子交换树脂纯化后, 采用tricine-SDS-PAGE测定类细菌素分子量, 并测定了类细菌素的部分特性。KLDS1.0364产生的类细菌素分子量约为21.6kD, 对热和pH值稳定, 可被多种蛋白酶失活, 不能被过氧化氢酶和α-淀粉酶失活。KLDS1.0364产生的类细菌素的作用方式是杀菌, 且抑菌谱广, 可抑制多种革兰氏阳性菌、革兰氏阴性菌和真菌。     

一株布氏乳杆菌所产类细菌素的初步纯化与部分特性

从分离自内蒙古传统乳制品的67株乳酸菌中筛选得到一株产生类细菌素的布氏乳杆菌KLDS1.0364,对其所产类细菌素进行初步分离纯化,同时研究其所产类细菌素的生物学特性.KLDS1.0364无细胞发酵上清液经阳离子交换树脂纯化后,采用tricine-SDS-PAGE测定类细菌素分子量,并测定了类细菌素的部分特性.KLDS1.0364产生的类细菌素分子量约为21.6kD,对热和pH值稳定,可被多种蛋白酶失活,不能被过氧化氢酶和α-淀粉酶失活.KLDS1.0364产生的类细菌素的作用方式是杀菌,且抑菌谱广,可抑制多种革兰氏阳性菌、革兰氏阴性菌和真菌.     

细菌的群体感应及与病原菌致病性的关系

微生物的群体感应(quorum sensing,QS)也称为自诱导,是微生物间通过小分子分泌物(自诱导物)在细胞与细胞之间扩散以感知群体密度,并通过自诱导物的浓度及其与转录因子的相互作用调控整个群体细胞中一系列目标基因表达的一种自我感知系统.不同的细菌类型,其QS系统也有一定的差异.根据信号分子的不同,一般可以将细菌的QS系统分为3类,即以AHL为信号分子的革兰氏阴性细菌、以寡肽类物质为信号分子的革兰氏阳性细菌和以哈氏弧菌为代表的兼具上述两种类型QS系统特征的第三类QS系统.综述革兰氏阴性细菌、革兰氏阳性细菌和哈氏弧菌的3种不同QS系统及其在病原菌致病性方面的研究进展.     

环境胁迫和非胁迫条件下类植物乳杆菌转录组分析

【背景】类植物乳杆菌L-ZS9是一株在食品发酵与保鲜方面具有潜在应用价值的产细菌素益生菌。【目的】深入了解环境胁迫影响类植物乳杆菌L-ZS9细菌素合成的重要相关调节基因的信息。【方法】通过高通量测序技术对类植物乳杆菌转录组进行测序,对所有转录本进行COG(Clusters of Orthologous Groups)、GO(Gene Ontology)和KEGG(Kyoto Encyclopedia of Genes and Genomes)分类和Pathway注释。【结果】转录组测序显示2个样品基因覆盖度都在90%以上,差异表达基因927个,其中744个上调,183个下调。KEGG分析结果表明,649个差异表达基因中68个集中在"ABC转运途径",占10.48%,其中3个基因表达上调超过16倍,1个基因表达下调超过1/16,暗示类植物乳杆菌L-ZS9细菌素合成与"ABC转运途径"密切相关。另外多个孤儿基因表达变化也超过16倍,有的甚至表达上调达万倍。【结论】进一步拓展了类植物乳杆菌的基因信息,为类植物乳杆菌细菌素代谢途径和逆境反应研究提供了坚实的基础。     

Lack of Heterogeneity in Bacteriocin Production Across a Selection of Commercial Probiotic Products

Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit to the host. Bacteriocin production has often been mooted as a desirable probiotic trait and, in specific cases, has been shown to promote probiotic survival within the gastrointestinal tract, contribute to the control of pathogens and even influence host gene expression in the gut. However, it is not clear what proportion of probiotic strains routinely found in commercial products produces bacteriocins, and additionally, it is not known which bacteriocins are produced most frequently. To address this, we conducted a culture-based assessment of the bacteriocinogenic ability of bacterial strains found in a variety of commercially available probiotic products. We detected eight bacteriocin-producing isolates from 16 tested products. Interestingly, in all cases, the isolates were Lactobacillus acidophilus, and the bacteriocin produced was identified as the narrow spectrum class II bacteriocin, lactacin B. The apparent absence of other bacteriocin-producing strains from across these products suggests a lack of heterogeneity in bacteriocin production within probiotic products and suggests that bacteriocin production is not being optimally harnessed as a probiotic trait.     

BlpC-regulated bacteriocin production in Streptococcus thermophilus

Streptococcus thermophilus B59671 produces a bacteriocin with anti-pediococcal activity, but genes required for its production are not characterized. Genome sequencing of S. thermophilus has identified a genetic locus encoding a quorum sensing (QS) system that regulates production of class II bacteriocins. However, in strains possessing this gene cluster, production of bacteriocin like peptides (Blp) was only observed when excess pheromone was provided. PCR analysis revealed this strain possessed blpC, which encodes the 30-mer QS pheromone. To investigate if BlpC regulates bacteriocin production in S. thermophilus B59671, an integrative vector was used to replace blpC with a gene encoding for kanamycin resistance and the resulting mutant did not inhibit the growth of Pediococcus acidilactici. Constitutive expression of blpC from a shuttle vector restored the bacteriocin production, confirming the blp gene cluster is essential for bacteriocin activity in S. thermophilus B59671.     

Pangenome analyses of LuxS-coding genes and enzymatic repertoires in cocoa-related lactic acid bacteria

Lactobacillaceae presents potential for interspecific Quorum Sensing (QS) in spontaneous cocoa fermentation, correlated with high abundance of luxS. Three Brazilian isolates from cocoa fermentation were characterized by Whole Genome Sequencing and luxS gene was surveyed in their genomes, in comparison with public databases. They were classified as Lactiplantibacillus plantarum, Limosilactobacillus fermentum and Pediococcus acidilactici. LuxS genes were conserved in core genomes of the novel isolates, but in some non-cocoa related Lactic Acid Bacteria (LAB) it was accessory and plasmid-borne. The conservation and horizontal acquisition of luxS reinforces that QS is determinant for bacterial adaptation in several environments, especially taking into account the luxS has been correlated with modulation of bacteriocin production, stress tolerance and biofilm formation. Therefore, in this paper, new clade and species-specific primers were designed for future application for screening of luxS gene in LAB to evaluate the adaptive potential to diverse food fermentations.     

Potential of bacteriocin-producing lactic acid bacteria for improvements in food safety and quality

Lactic acid bacteria (LAB) have been used for centuries in the fermentation of a variety of dairy products. The preservative ability of LAB in foods is attributed to the production of anti-microbial metabolites including organic acids and bacteriocins. Bacteriocins generally exert their anti-microbial action by interfering with the cell wall or the membrane of target organisms, either by inhibiting cell wall biosynthesis or causing pore formation, subsequently resulting in death. The incorporation of bacteriocins as a biopreservative ingredient into model food systems has been studied extensively and has been shown to be effective in the control of pathogenic and spoilage microorganisms. However, a more practical and economic option of incorporating bacteriocins into foods can be the direct addition of bacteriocin-producing cultures into food. This paper presents an overview of the potential for using bacteriocin-producing LAB in foods for the improvement of the safety and quality of the final product. It describes the different genera of LAB with potential as biopreservatives, and presents an up-to-date classification system for the bacteriocins they produce. While the problems associated with the use of some bacteriocin-producing cultures in certain foods are elucidated, so also are the situations in which incorporation of the bacteriocin-producer into model food systems have been shown to be very effective.     

An analysis of bacteriocins produced by lactic acid bacteria isolated from malted barley

AIMS: The aim of this study was to perform a detailed characterization of bacteriocins produced by lactic acid bacteria (LAB) isolated from malted barley. METHODS AND RESULTS: Bacteriocin activities produced by eight LAB, isolated from various types of malted barley, were purified to homogeneity by ammonium sulphate precipitation, cation exchange, hydrophobic interaction and reverse-phase liquid chromatography. Molecular mass analysis and N-terminal amino acid sequencing of the purified bacteriocins showed that four non-identical Lactobacillus sakei strains produced sakacin P, while four Leuconostoc mesenteroides strains were shown to produce bacteriocins highly similar or identical to leucocin A, leucocin C or mesenterocin Y105. Two of these bacteriocin-producing strains, Lb. sakei 5 and Leuc. mesenteroides 6, were shown to produce more than one bacteriocin. Lactobacillus sakei 5 produced sakacin P as well as two novel bacteriocins, which were termed sakacin 5X and sakacin 5T. The inhibitory spectrum of each purified bacteriocin was analysed and demonstrated that sakacin 5X was capable of inhibiting the widest range of beer spoilage organisms. CONCLUSION: All bacteriocins purified in this study were class II bacteriocins. Two of the bacteriocins have not been described previously in the literature while the remaining purified bacteriocins have been isolated from environments other than malted barley. SIGNIFICANCE AND IMPACT OF THE STUDY: This study represents a thorough analysis of bacteriocin-producing LAB from malt and demonstrates, for the first time, the variety of previously identified and novel inhibitory peptides produced by isolates from this environment. It also highlights the potential of these LAB cultures to be used as biological controlling agents in the brewing industry.     

Combined effect of high-pressure treatments and bacteriocin-producing lactic acid bacteria on inactivation of Escherichia coli O157:H7 in raw-milk cheese

The effect of high-pressure (HP) treatments combined with bacteriocins of lactic acid bacteria (LAB) produced in situ on the survival of Escherichia coli O157:H7 in cheese was investigated. Cheeses were manufactured from raw milk inoculated with E. coli O157:H7 at approximately 10(5) CFU/ml. Seven different bacteriocin-producing LAB were added at approximately 10(6) CFU/ml as adjuncts to the starter. Cheeses were pressurized on day 2 or 50 at 300 MPa for 10 min or 500 MPa for 5 min, at 10 degrees C in both cases. After 60 days, E. coli O157:H7 counts in cheeses manufactured without bacteriocin-producing LAB and not pressurized were 5.1 log CFU/g. A higher inactivation of E. coli O157:H7 was achieved in cheeses without bacteriocin-producing LAB when 300 MPa was applied on day 50 (3.8-log-unit reduction) than if applied on day 2 (1.3-log-unit reduction). Application of 500 MPa eliminated E. coli O157:H7 in 60-day-old cheeses. Cheeses made with bacteriocin-producing LAB and not pressurized showed a slight reduction of the pathogen. Pressurization at 300 MPa on day 2 and addition of lacticin 481-, nisin A-, bacteriocin TAB 57-, or enterocin AS-48-producing LAB were synergistic and reduced E. coli O157:H7 counts to levels below 2 log units in 60-day-old cheeses. Pressurization at 300 MPa on day 50 and addition of nisin A-, bacteriocin TAB 57-, enterocin I-, or enterocin AS-48-producing LAB completely inactivated E. coli O157:H7 in 60-day-old cheeses. The application of reduced pressures combined with bacteriocin-producing LAB is a feasible procedure to improve cheese safety.     

Lyophilized preparations of bacteriocinogenic Lactobacillus curvatus and Lactococcus lactis subsp. lactis as potential protective adjuncts to control Listeria monocytogenes in dry-fermented sausages

AIM: Study of the effectiveness of in situ bacteriocin production by lactic acid bacteria (LAB) to control Listeria monocytogenes in dry-fermented sausages. METHODS AND RESULTS: Two bacteriocin-producing strains: Lactococcus lactis subsp. lactis LMG21206 and Lactobacillus curvatus LBPE were grown in a pilot scale fermentor and lyophilized to be directly used in dry sausage fermentation. A commercial starter culture (Bel'meat SL-25) not inhibitory to L. monocytogenes (Bac- starter) was mixed (1 : 1) with each of the two lyophilized bacteriocin-producing strains to obtain starters active against the pathogen (Bac+ starter). Anti-Listeria effectiveness of the Bac+ starters was studied in dry-fermented sausages. The meat batter was experimentally contaminated with a mixture of four different strains of L. monocytogenes (10(2)-10(3) CFU g(-1)). The results showed that L. monocytogenes did not grow in any of the contaminated batches, but no significant decrease (P > 0.05) was observed either in the positive control (no added starter culture) or in samples fermented with the Bac- starter culture during the fermentation period and up to 15 days of drying. When the Bac+ starter contained Lb. curvatus LBPE, cell counts of L. monocytogenes decreased to below the detectable limit (<10 CFU g(-1)) after 4 h of fermentation and no survivors could be recovered by enrichment beyond day 8 of drying. When the Bac+ starter culture containing Lc. lactis LMG21206 was used, a decrease in Listeria counts to below the detectable limit was achieved after 15 days of drying. CONCLUSIONS: The bacteriocin-producing strains studied may be used as adjunct cultures for sausage fermentations to control the occurrence and survival of L. monocytogenes. SIGNIFICANCE AND IMPACT OF THE STUDY: Addition of the Bac+ strains, especially the Lb. curvatus strain would provide an additional hurdle to enhance the control of L. monocytogenes in fermented meat products.     

Combined Effect of High-Pressure Treatments and Bacteriocin-Producing Lactic Acid Bacteria on Inactivation of Escherichia coli O157:H7 in Raw-Milk Cheese

The effect of high-pressure (HP) treatments combined with bacteriocins of lactic acid bacteria (LAB) produced in situ on the survival of Escherichia coli O157:H7 in cheese was investigated. Cheeses were manufactured from raw milk inoculated with E. coli O157:H7 at approximately 10⁵ CFU/ml. Seven different bacteriocin-producing LAB were added at approximately 10⁶ CFU/ml as adjuncts to the starter. Cheeses were pressurized on day 2 or 50 at 300 MPa for 10 min or 500 MPa for 5 min, at 10°C in both cases. After 60 days, E. coli O157:H7 counts in cheeses manufactured without bacteriocin-producing LAB and not pressurized were 5.1 log CFU/g. A higher inactivation of E. coli O157:H7 was achieved in cheeses without bacteriocin-producing LAB when 300 MPa was applied on day 50 (3.8-log-unit reduction) than if applied on day 2 (1.3-log-unit reduction). Application of 500 MPa eliminated E. coli O157:H7 in 60-day-old cheeses. Cheeses made with bacteriocin-producing LAB and not pressurized showed a slight reduction of the pathogen. Pressurization at 300 MPa on day 2 and addition of lacticin 481-, nisin A-, bacteriocin TAB 57-, or enterocin AS-48-producing LAB were synergistic and reduced E. coli O157:H7 counts to levels below 2 log units in 60-day-old cheeses. Pressurization at 300 MPa on day 50 and addition of nisin A-, bacteriocin TAB 57-, enterocin I-, or enterocin AS-48-producing LAB completely inactivated E. coli O157:H7 in 60-day-old cheeses. The application of reduced pressures combined with bacteriocin-producing LAB is a feasible procedure to improve cheese safety.     

A spatial model of the evolution of quorum sensing regulating bacteriocin production

Like any form of cooperative behavior, quorum sensing (QS) inbacteria is potentially vulnerable to cheating, the occurrenceof individuals that contribute less but still profit from thebenefits provided by others. In this paper, we explore the evolutionarystability of QS as a regulatory mechanism of antibiotics productionin a spatially structured population, using cellular automaton(CA) modeling. QSg is supposed to regulate the excretion ofa bacteriocin (anticompetitor toxin) in a population of bacteriapolymorphic for the ability to produce and to be immune to thebacteriocin. Both the social interactions resulting from QSand the competitive interactions resulting from the bacteriocinexcretion are supposed to be only effective at the local scale,that is, restricted to the immediately neighboring cells. Thisimplies a rather diffuse kind of group selection. The CA modelis contrasted to a model assuming no spatial structure but withotherwise identical assumptions. Our analysis predicts thatQS as a regulatory mechanism of bacteriocin excretion is evolutionarilyunstable when the competitive interactions between bacteriocin-producing,resistant, and sensitive strains only involve closely relatedstrains which can share the signaling and responding genes involvedin QS. However, when the competition is between unrelated strainsand the QS alleles can only be carried by the bacteriocin-producingstrains, stable QS may evolve provided its costs are small andthe critical quorum threshold is neither too low nor too high.     

Capacity of human nisin- and pediocin-producing lactic Acid bacteria to reduce intestinal colonization by vancomycin-resistant enterococci

This study demonstrated the capacity of bacteriocin-producing lactic acid bacteria (LAB) to reduce intestinal colonization by vancomycin-resistant enterococci (VRE) in a mouse model. Lactococcus lactis MM19 and Pediococcus acidilactici MM33 are bacteriocin producers isolated from human feces. The bacteriocin secreted by P. acidilactici is identical to pediocin PA-1/AcH, while PCR analysis demonstrated that L. lactis harbors the nisin Z gene. LAB were acid and bile tolerant when assayed under simulated gastrointestinal conditions. A well diffusion assay using supernatants from LAB demonstrated strong activity against a clinical isolate of VRE. A first in vivo study was done using C57BL/6 mice that received daily intragastric doses of L. lactis MM19, P. acidilactici MM33, P. acidilactici MM33A (a pediocin mutant that had lost its ability to produce pediocin), or phosphate-buffered saline (PBS) for 18 days. This study showed that L. lactis and P. acidilactici MM33A increased the concentrations of total LAB and anaerobes while P. acidilactici MM33 decreased the Enterobacteriaceae populations. A second in vivo study was done using VRE-colonized mice that received the same inocula as those in the previous study for 16 days. In L. lactis-fed mice, fecal VRE levels 1.73 and 2.50 log(10) CFU/g lower than those in the PBS group were observed at 1 and 3 days postinfection. In the P. acidilactici MM33-fed mice, no reduction was observed at 1 day postinfection but a reduction of 1.85 log(10) CFU/g was measured at 3 days postinfection. Levels of VRE in both groups of mice treated with bacteriocin-producing LAB were undetectable at 6 days postinfection. No significant difference in mice fed the pediocin-negative strain compared to the control group was observed. This is the first demonstration that human L. lactis and P. acidilactici nisin- and pediocin-producing strains can reduce VRE intestinal colonization.